Expression Profiling of microRNA Following Administration of Dexmedetomidine
NCT03213743
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Coronary Disease
Interventions
DRUG:
Dexmedetomidine Injection
Sponsor
First Affiliated Hospital of Kunming Medical University